Mortality and cause of death in mucopolysaccharidosis type II—a historical review based on data from the Hunter Outcome Survey (HOS)
Simon Jones(Manchester University NHS Foundation Trust), Lawrence A. Lavery(The University of Texas at San Antonio), Shau‐Ping Lin(National Taiwan University), Uma Ramaswami(The Royal Free Hospital), Zsuzsanna Almássy(Boston Children's Hospital), Radka Tincheva(National Hospital for Neurology and Neurosurgery), Karen Burt(Manchester Academic Health Science Centre), Christian J. Hendriksz(Birmingham Children's Hospital), Roberto Giugliani(Universidade Federal do Rio Grande do Sul), Michael Beck(Eastern Illinois University), Joe T.R. Clarke(Dalhousie University), J. E. Wraith(Boston Children's Hospital), Gunilla Malm(Karolinska University Hospital), T Kroepfl(Graz University Hospital)
Cited by 183
Related Papers
Global vascular guidelines on the management of chronic limb-threatening ischemia
|Journal of Vascular Surgery|2019|1.9k
Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia
|European Journal of Vascular and Endovascular Surgery|2019|1.5k
Validation of a Diabetic Wound Classification System: The contribution of depth, infection, and ischemia to risk of amputation
|Diabetes Care|1998|1.1k
Negative pressure wound therapy after partial diabetic foot amputation: a multicentre, randomised controlled trial
|The Lancet|2005|951
Comprehensive Foot Examination and Risk Assessment
|Diabetes Care|2008|917